133 related articles for article (PubMed ID: 20637053)
1. No interference of the 1,3-β-D-glucan containing nutritional supplement ImunixX with the 1,3-β-D-glucan serum test.
Spriet I; Desmet S; Willems L; Lagrou K
Mycoses; 2011 Sep; 54(5):e352-3. PubMed ID: 20637053
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
Pini P; Bettua C; Orsi CF; Venturelli C; Forghieri F; Bigliardi S; Faglioni L; Luppi F; Serio L; Codeluppi M; Luppi M; Mussini C; Girardis M; Blasi E
Infection; 2016 Apr; 44(2):223-33. PubMed ID: 26475482
[TBL] [Abstract][Full Text] [Related]
3. Role of serum (1,3)-β-d-glucan assay in early diagnosis of invasive fungal infections in a neonatal intensive care unit.
Shabaan AE; Elbaz LM; El-Emshaty WM; Shouman B
J Pediatr (Rio J); 2018; 94(5):559-565. PubMed ID: 29144965
[TBL] [Abstract][Full Text] [Related]
4. The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.
Alexander BD; Smith PB; Davis RD; Perfect JR; Reller LB
J Clin Microbiol; 2010 Nov; 48(11):4083-8. PubMed ID: 20720025
[TBL] [Abstract][Full Text] [Related]
5. Bloodstream infections are an improbable cause of positive serum (1,3)-β-D-glucan in hematology patients.
Furfaro E; Mikulska M; Del Bono V; Guolo F; Minetto P; Gobbi M; Ghiso A; Bacigalupo A; Viscoli C
Clin Vaccine Immunol; 2014 Sep; 21(9):1357-9. PubMed ID: 24990906
[TBL] [Abstract][Full Text] [Related]
6. Clinical viability of Fungitell, a new (1→3)-β-D: -glucan measurement kit, for diagnosis of invasive fungal infection, and comparison with other kits available in Japan.
Yoshida K; Shoji H; Takuma T; Niki Y
J Infect Chemother; 2011 Aug; 17(4):473-7. PubMed ID: 21210174
[TBL] [Abstract][Full Text] [Related]
7. Serum glucuronoxylomannan may be more appropriate for the diagnosis and therapeutic monitoring of Trichosporon fungemia than serum β-D-glucan.
Liao Y; Hartmann T; Ao JH; Yang RY
Int J Infect Dis; 2012 Aug; 16(8):e638. PubMed ID: 22640630
[No Abstract] [Full Text] [Related]
8. Reappraisal of the serum (1-->3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years.
Obayashi T; Negishi K; Suzuki T; Funata N
Clin Infect Dis; 2008 Jun; 46(12):1864-70. PubMed ID: 18462174
[TBL] [Abstract][Full Text] [Related]
9. Reactivity of (1→3)-β-d-glucan assay in bacterial bloodstream infections.
Albert O; Toubas D; Strady C; Cousson J; Delmas C; Vernet V; Villena I
Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1453-60. PubMed ID: 21479838
[TBL] [Abstract][Full Text] [Related]
10. Is elevation of the serum β-d-glucan level a paradoxical sign for trichosporon fungemia in patients with hematologic disorders?
Nakase K; Suzuki K; Kyo T; Kohara T; Sugawara Y; Katayama N
Int J Infect Dis; 2012 Jan; 16(1):e2-e4. PubMed ID: 22071235
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
Persat F; Ranque S; Derouin F; Michel-Nguyen A; Picot S; Sulahian A
J Clin Microbiol; 2008 Mar; 46(3):1009-13. PubMed ID: 18160456
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of serum β-d-glucan levels in 78 patients with Trichosporon fungemia.
Kushima H; Ishii H; Komiya K; Tokimatsu I; Kadota J
Int J Infect Dis; 2013 Feb; 17(2):e134-5. PubMed ID: 22832213
[No Abstract] [Full Text] [Related]
13. Can bacteraemia lead to false positive results in 1,3-beta-D-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections.
Metan G; Koc AN; Ağkuş Ç; Kaynar LG; Alp E; Eser B
Rev Iberoam Micol; 2012; 29(3):169-71. PubMed ID: 21907303
[TBL] [Abstract][Full Text] [Related]
14. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.
Metan G; Ağkuş C; Buldu H; Koç AN
Infection; 2010 Jun; 38(3):217-21. PubMed ID: 20237947
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.
Pickering JW; Sant HW; Bowles CA; Roberts WL; Woods GL
J Clin Microbiol; 2005 Dec; 43(12):5957-62. PubMed ID: 16333082
[TBL] [Abstract][Full Text] [Related]
16. Detection of plasma (1 --> 3)-beta-D-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias.
Yoshida M; Obayashi T; Iwama A; Ito M; Tsunoda S; Suzuki T; Muroi K; Ohta M; Sakamoto S; Miura Y
J Med Vet Mycol; 1997; 35(5):371-4. PubMed ID: 9402532
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.
Alam FF; Mustafa AS; Khan ZU
BMC Infect Dis; 2007 Sep; 7():103. PubMed ID: 17784947
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum beta-D-glucan level and depressed neutrophil phagocytosis in a heatstroke patient.
Aibiki M; Ohtsubo S; Nishiyama T; Maekawa S; Oka H; Dote K; Shirakawa Y
Resuscitation; 2005 Apr; 65(1):115-7. PubMed ID: 15797285
[TBL] [Abstract][Full Text] [Related]
19. Transience of interference in an immunoassay measuring serum levels of beta-D-glucan.
Prince HE; Batterman HJ; Realegeno SE; Marlowe EM
Diagn Microbiol Infect Dis; 2022 Apr; 102(4):115630. PubMed ID: 35074622
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the clinical cutoff level of serum (1 --> 3)-beta-D-glucan in patients with connective tissue diseases complicated by deep fungal infections.
Kato K; Onoda S; Asano J; Fukaya S; Yoshida S
Mod Rheumatol; 2010 Aug; 20(4):366-9. PubMed ID: 20349101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
